摘要
目的探讨临床治疗对慢性充血性心力衰竭患者心率变异性的影响。方法选取60例于2013年5月至2015年5月期间我院收治的慢性充血性心力衰竭患者,随机分为对照组(常规治疗,n=30)与实验组(常规治疗+曲美他嗪治疗,n=30),观察两组的心率变异性指标及心功能指标变化。结果治疗后,两组的心率、LVEDd均较治疗前显著下降,LVEF、6-MWD均显著升高(P<0.05),实验组的各项指标均显著优于对照组(P<0.05)。治疗后,两组的pNN50、SDANN、SDNN、rMSSD均显著升高(P<0.05),实验组各项指标均显著高于对照组(P<0.05)。结论慢性充血性心力衰竭采用曲美他嗪治疗,可显著改善患者的心率变异性,具有推广价值。
Objective To explore the effect of clinical treatment on the heart rate variability of patients with chronic congestive heart failure. Methods 60 cases of patients with chronic congestive heart failure admitted to our hospital from May 2013 to May 2015 were selected and randomly divided into two groups, with 30 cases in each group. The control group received routine treatment, while the experimental group received sibutramine trimetazidine treatment on the basis of routine treatment. The heart rate variability indicators and heart fimction indicators of two groups were observed. Results After treatment, both groups had significantly decreased heart rate and LVEDd, and increased LVEF and 6-MWD （P 〈0.05）, while the indicators of experimental group were significantly better than those of control group （P〈0.05）. After treatment, both groups had significantly increased pNN50, SDANN, SDNN and rMSSD （P〈0.05）, and the indicators of experimental group were significantly higher than those of control group （P 〈0.05）. Conclusions Sibutrarnine trimetazidine treatment for chronic congestive heart failure can obviously improve patients＇ heart rate variability, which has the value of promotion.
作者
黄培清
HUANG Peiqing(Yangchun Hospital of Traditional Chinese Medicine, Yangchun 529600, Chin)
出处
《临床医学工程》
2016年第12期1653-1654,共2页
Clinical Medicine & Engineering
关键词
心率变异性
慢性充血性心力衰竭
临床治疗
Heart rate variability
Chronic congestive heart failure
Clinical treatment
